ANXA2 and neoplasm: ANXA2 heterotetramers bind to tPA to mediate the activation of plasminogen to plasmin, which facilitates degradation of the extracellular matrix and proteolytic activation of inactive proteases, such as matrix metalloproteases, leading to increased angiogenesis, migration, invasion, and metastasis of tumor cells.